OGN – organon & co. (US:NASDAQ)
Stock Stats
News
Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade) [Seeking Alpha]
Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know [Yahoo! Finance]
Organon Reports Results for the Third Quarter Ended September 30, 2024
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
Form 4 Organon & Co. For: Nov 07 Filed by: Arjona Ferreira Juan Camilo
Form 8-K Organon & Co. For: Nov 05
Form 10-Q Organon & Co. For: Sep 30
Form 8-K Organon & Co. For: Oct 31
Form 8-K Organon & Co. For: Sep 17
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.